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Subscapular artery Y-shaped flow-through muscle
flap: A novel one-stage limb salvage procedure
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Dominique Casanova, MD, PhD,c and Alain Branchereau, MD,a Marseille, France
Objectives: Major tissue loss caused by the critical limb ischemia requires improvement of distal perfusion and cover of
large tissue defects. We propose a new method, the Y-shaped subscapular artery flow-through (Y-SCAFT) muscle flap
using the subscapular artery that yields an arterial graft and a free muscle flap sustained by a collateral branch of this
artery. This prospective study evaluated the feasibility of this technique and analyzed wound healing, graft patency, and
limb salvage.
Methods: Between 2002 and 2007, 20 patients, mean age 64 years (range, 55-79 years), were treated with this technique.
All presented with critical ischemia and major tissue loss, with exposure of the tendons, bones, or joint, and were
candidates for major amputation. Revascularization and cover of tissue loss with the same Y-SCAFT anatomic unit was
used for all patients. The distal anastomosis was performed between the distal branch of the Y-SCAFT and the pedal
artery in 9, posterior tibial artery in 4, peroneal artery in 1, lateral tarsal artery in 3, and the plantar artery in 3. In four
patients, the distal part of the arterial graft, including the anastomosis, was covered with the muscle flap because the tissue
loss was nearby. The proximal anastomosis was performed between a leg artery and the arterial graft in 10 patients. A
venous graft was necessary in 10 patients to extend the bypass proximally.
Results: One patient died during the postoperative period. Duplex control evidenced patency all the Y-SCAFT muscle
flaps. Healing was achieved in all patients. Mean follow-up was 31 months (range, 6-58 months). No patients died during
follow-up. One patient presented occlusion of the Y-SCAFT muscle flap and underwent amputated. One patient had
major amputation despite a patent graft. At 2 years, leg salvage was 85%, patency was 94%, and survival was 94%. At the
end of the follow-up, 17 patients (1 death, 2 amputations) had a patent graft, a viable muscle flap, wound healing, and
a functional leg.
Conclusion: We showed the clinical feasibility of the technique of Y-SCAFT muscle flap, which allows for
revascularization and cover of major tissue loss with one anatomic unit. This method is particularly useful in selected
cases with poor run-off and large ischemic lesions. ( J Vasc Surg 2008;48:159-66.)The tissue loss is the most frequent symptom of
critical limb ischemia.1 Aggressive treatment of ischemia
of the lower extremities has decreased the number of
amputations.2 Despite vascular reconstruction, the lower
extremity is threatened by a major amputation when
bone, tendon, vascular graft, or graft material is ex-
posed.3 Currently, combined surgery associating a distal
bypass and a free flap seems to be the technique that
yields the best results. The recently demonstrated hemo-
dynamic advantages of this technique are the increase in
bypass flow.4 Nevertheless, it is a complex and time-
consuming surgical technique, and the multiplication of
anastomoses on the same arterial axis may induce in-
creasing risk of thrombosis.
The idea of using the same anatomic unit for revas-
cularization and coverage was first published by Gooden
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flow-through (RAFT) flap for limb salvage. The applica-
tion of an arterial autograft for distal revascularization of
the lower limbs presents considerable advantages.6,7
This concept is very attractive, but the RAFT flap is a
fasciocutaneous flap with poor blood flow and therefore
does not have a hemodynamic advantage.8 Also, the
RAFT flap provides tissue cover only in the axial plane of
the radial artery conduit.
To combine the advantages of the arterial autograft, an
increased run-off due to the muscular flap, and the possi-
bility of covering the tissue loss with the same anatomic
unit, we suggest a new technique: the subscapular artery
Y-shaped flow-through (Y-SCAFT) muscle flap.9 This is an
anatomic unit based on the subscapular artery that yields an
arterial graft and a free flap sustained by a collateral branch
of the graft (Fig 1). The arterial autograft is composed of
the subscapular artery extended by the thoracodorsal ar-
tery. The free flap is composed of the serratus anterior
muscle supplied by the distal branch of the thoracodorsal
artery. Surgical anatomy and harvesting technique were
published previously.10 This prospective study evaluated
the feasibility of this technique and analyzed the results of
the first 20 patients that otherwise would have undergone
major amputation.We hypothesized that the Y-SCAFT flap
would be an efficacious treatment for limb salvage in the
worst situation of critical limb ischemia.
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Patients. Between August 2002 and January 2007, 20
patients were selected. All the patients presented with ma-
jor ischemic tissue loss of the lower limbs (category 6 of
Rutherford classification).11 Patient information was en-
tered prospectively into a database. During the same pe-
riod, four other patients underwent hybrid surgery for
combined distal bypass and free flap transfer, and alto-
gether, 590 patients were operated on for critical limb
ischemia.
Patient demographic data included age, sex, vascular
risk factors, previous vascular procedures, and type of pre-
senting symptom (rest pain or necrosis). The description of
limb lesions included a description of the nature and extent
of the tissue loss. The wound surface was evaluated by
means of cross-ruled transparent film. Blood pressure at
ankle level, ankle-brachial index (ABI), and transcutaneous
oxygen pressure (TcPO2) weremeasured. The extent of the
vascular disease was assessed by digital subtraction angiog-
raphy, and images were scored by the method proposed by
the Ad Hoc Committee on Reporting Standards of the
Society for Vascular Surgery and International Society for
Cardiovascular Surgery.12
Hospital care data included length of stay, details (in-
flow, outflow, operative data), secondary procedures (graft
revision, wound débridement), and hospital complications.
Longitudinal functional outcome included time of wound
healing, need for additional procedures for wound care,
Fig 1. Concept of the Y-shaped flow-through free flap: anatomic
unit composed of a vascular axis that yields an arterial graft (bypass)
with its distal collateral Y-shaped branch supplying a cutaneous or
muscle patch (flap).ambulatory status, and aesthetic status of the graft.All patients had an adequate psychologic profile allow-
ing this complex surgical challenge: they were cooperative,
willing, and well informed. Dialysis for renal insufficiency
was the only contraindication.
Operative procedure. A two-team approach was used
in all cases. First, necrotic tissue was débrided to determine
the extent of the defect and to eliminate florid infection; if
necessary, a minor amputation was performed.
Second, the operation was continued in two separate
clean fields. The vascular surgeon performed the prepara-
tion of the anastomotic sites of the bypass and the plastic
surgeon raised the Y-SCAFT flap. Surgical anatomy and
harvesting technique of Y-SCAFT flap have previously been
described,8,9 The Y-SCAFT anatomic unit was transferred
onto the tissue loss and the revascularization performed by
means of the autogenous arterial graft. A microsurgical
technique was used in all cases. An internal saphenous vein
graft segment was used to extend the proximal part of the
graft when the lesion was too long to be bypassed solely by
the arterial autograft. Distal anastomosis was performed
between the distal branch of the Y-SCAFT flap and one of
the foot arteries. The vein of the flap was anastomosed to a
deep vein of the foot or leg. All patients underwent a
completion angiogram at the end of the procedure.
A cutaneous graft, generally a thin, skin graft, was
performed on the muscle flap 1 week after the intervention.
In three patients, where the flap was positioned around the
plantar area, we applied a full-thickness skin graft to cover
the weight-bearing surface.
Medication. Systemic heparinization was used during
surgery. Postoperatively, the patients were given nonfraction-
ated heparin intravenously for 48 hours. Low-molecular-
weight heparin therapywas started on postoperative day 3 and
extended to 3 weeks. All patients received a prophylactic
antibiotic, and the postoperative therapy was continued ac-
cording to bacterial cultures achieved during surgery. Acetyl-
salicylic acid was used as antiplatelet therapy permanently,
with the exception of the patients already taking anticoagula-
tion medication for concomitant disease.
Postoperative surveillance and follow-up. All pa-
tients were monitored in the intensive care unit or the
recovery room for the first 24 hours so that the vitality of
the Y-SCAFT flap could be checked by clinical monitoring
and by duplex ultrasound (DUS) scanning, as appropriate.
Patients were kept on bed rest for 4 days, with the limb
elevated. Ambulation was started gradually, with exercises
in the standing position. Weight-bearing exercise was al-
lowed only after 2 to 3 weeks. Patients were reviewed daily
for the first 10 days and thereafter as required until wound
healing was completed.
The follow-up was prospective. The first follow-up visit
was at 1 month, thereafter at 3, 6, and 12months, and then
annually, depending on the healing of the foot. At each
visit, the viability of the flap was recorded as well as the
patency of the vascular graft byDUS imaging. Angiography
was performed during follow-up in 13 patients for other
lesions caused by arterial occlusion. The elements checked
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rate, arterial distal pressure, and healing.
Statistics. Data of the blood pressure at ankle level,
ABI, and TcPO2 are presented as median and interquartile
range (IQR). Because sample size was small, nonparametric
paired two-sided tests (Wilcoxon test) were preferred and
used to evaluate changes after surgery. Values of P  .05
were taken to be statistically significant. Patient survival,
graft patency, and limb salvage were calculated with
Kaplan-Meier method and the curves were plotted. All
statistical analyses were performed using SPSS 15.0 soft-
ware (SPSS Inc, Chicago, Ill).
RESULTS
The 20 patients (4 women) were a mean age 64 years
(range, 55-79 years). Six patients were current smokers, 17
had diabetes mellitus, 9 had hypertension, and 14 had
coronary disease. Thirteen patients had already undergone
previous vascular interventions, including bypass arterial
reconstruction (n  5) and percutaneous transluminal an-
gioplasty (n 8). Six patients had previous forefoot ampu-
tation, and in seven cases, toe amputation had been per-
formed.
All the patients presented with critical limb ischemia
and important tissue loss resulting from arterial occlusive
disease of the lower limbs. All had rest pain. Median blood
pressure at ankle level was 30 mm Hg (range, 20-50 mm
Hg), median ABI was 0.2 (range 0.1-0.4), and mean
TcPO2 was 18 mm Hg (range, 10-28 mm Hg).
The average wound surface area was 55 cm2 (range,
30-120 cm2). In 16 patients, the wound was infected and
four were necrotic (“mummified”). In all patients, bone,
Table. Results of revascularisation of the lower limbs with
N Age Sex
Tissue loss
localisation
Run-off
score
Graft
material
Proxim
anasto
1 55 M malleolar 6 Y ant. tib
2 73 M plantar 4 Y  vein poplite
3 41 M malleolar 8 Y post. t
4 68 M forefoot 10 Y  vein poplite
5 71 M forefoot 7 Y ant. tib
6 76 M forefoot 4 Y ant. tib
7 43 M malleolar 6 Y post. t
8 72 F forefoot 4 Y  vein femora
9 78 F plantar 3 Y ant. tib
10 57 M forefoot 6 Y  vein femora
11 68 M forefoot 4 Y  vein poplite
12 59 M forefoot 4 Y ant. tib
13 72 M plantar 6 Y vein femora
14 59 M malleolar 3 Y post. t
15 63 M forefoot 4 Y perone
16 66 F forefoot 5 Y  vein poplite
17 48 M forefoot 3 Y  vein post. t
18 60 F forefoot 4 Y  vein poplite
19 79 M forefoot 6 Y ant. tib
20 74 M forefoot 4 Y  vein poplite
Run-off score according to the Ad Hoc 1–10 [10].
Y: shaped subscapular artery flow-through muscle flap (Y-SCAFT).joint, or tendon were exposed within the wound. Thedistance between the tissue loss and the site of the potential
distal anastomosis was 14 cm. This limitation was deter-
mined by our previous anatomic study of the Y-SCAFT
flap.9,10 The site of the potential distal anastomosis was
beneath necrotic skin in four patients. The tissue loss was
present on three major localizations: forefoot in 13, malle-
olar in four, and plantar in three. The median run-off
score10 was 5 (range, 3-10; Table).
Intraoperative data. All 20 operations were initially
successful, with graft patency and flap viability. The mean
operating time was 6 hours (range, 3 hours 20 minutes–7
hours 30 minutes). The mean duration of the flap ischemia
was 45 minutes (range, 35-90 minutes).
The donor artery for the proximal anastomosis was the
femoral artery in 3 patients, the popliteal artery in 6, the
anterior tibial artery in 6, the posterior tibial artery in 4, and
the peroneal artery in 1. Distal anastomosis was performed
using the distal branch of the Y-SCAFT flap: the thora-
codorsal artery was used in 15 patients and the circumflex
scapular artery in five.
The recipient artery for the distal anastomosis was
the pedal artery in 9 patients, the posterior tibial artery in
4, the peroneal artery in 1, the lateral tarsal artery in 3,
and the plantar artery in 3. In four patients, the distal
part of the arterial graft, including anastomosis, was
covered with the muscular flap because the tissue loss was
nearby.
Revascularization by means of one anatomic unit of
Y-SCAFT flap was possible in 10 patients for short lesions
of the leg arteries (Fig 2). The mean length of the arterial
autograft was 12.0 cm (range, 8.5-15.5 cm). In the 10
other patients, the internal saphenous vein was used to
AFT in 20 patients
Distal
anastomosis
Patency
of Y Limb salvage
Follow up
(months)
pedial a. yes yes 58
Pedial a. yes yes 54
. peroneal yes yes 50
post. tibial a. yes yes 48
post. tibial a. yes yes 46
pedial a. yes yes Diedat1m
. post. Tibial a. yes yes 45
pedial a. yes yes 43
lateral tarsal a. yes yes 40
post. tibia a. yes amputation (4m) 36
pedial a. yes yes 29
lateral tarsal a yes yes 25
pedial a. yes yes 23
plantar a yes yes 21
lateral tarsal a. yes yes 19
pedial a. yes yes 16
. plantar a. no amputation (5m) 14
pedial a. yes yes 12
pedial a. yes yes 10
plantar a. yes yes 6Y-SC
al
mosis
ial a.
al a.
ibial a
al a.
ial a.
ial a.
ibial a
l a.
ial
l a.
al a.
ial a.
l a.
ibial a
al a.
al a.
ibial a
al a.
ial a.
al a.extend proximal part of the graft.
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the foot or leg in all patients. The serratus anterior muscle
was used as the free flap in all patients.
Postoperative results. The overall 30-day mortality
rate was 5% after one of the 20 patients died at day 28 of
stercoral peritonitis not related to the intervention itself.
Major cardiac morbidity occurred in one patient, who
survived a perioperative myocardial infarction that pro-
longed his intensive care unit. One patient underwent
exploration for a hematoma of the wound.
The mean hospitalization was 22 days (range, 14-42
days), and mean time for recovering walking capacity was
15 days (range, 10-25 days). Healing was achieved in all
patients within an average of 32 days (range, 20-60 days).
Fig 2. A, Ischemic tissue loss of the forefoot. B, A preoperative
angiogram shows the occlusion of the posterior tibial artery and of
the peroneal artery, the stenoses of the anterior tibial artery, and its
occlusion at ankle level. The pedal artery is reinjected. C, An
intraoperative image shows the muscle flap. D, A drawing shows
the subscapular artery Y-shaped flow-through (Y-SCAFT) muscle
flap supplying the pedal artery from the anterior tibial artery. E,
Flap at 16 months. F, A completion angiogram at 16 months
shows the patency of the bypass, the distal anastomosis to the pedal
artery (filled arrow), and the patency of the artery of the flap (clear
arrow).We did not observe infection of the flap. Delayed woundhealing occurred on one harvest site of the saphenous vein
and was treated by secondary healing. The median postop-
erative blood pressure at the ankle level was 110 mm Hg
(range, 90-140 mmHg). The difference compared with 30
mmHg pressure (range, 20-50mmHg) preoperatively was
significant (P  .001). The median ABI was 0.85 (range,
0.8-1.0; Fig 3). DUS control scans evidenced patency of all
the bypasses.
Long-term results. Mean follow-up of the patients
was 31months (range, 6-58months). No patients were lost
to follow-up and no further deaths occurred. The survival
rate of these patients was 94% at 2 years. Two patients
underwent major amputation. One patient, who had co-
agulopathy, presented occlusion of the Y-SCAFT leading
to below-knee amputation 5 months postoperatively. An-
other patient had above-knee amputation 4 months after
the operation because of persistent sepsis at the knee joint;
but in this patient, the Y-SCAFT was patent and the foot
had healed. No secondary procedure was necessary in the
other 17 patients. The wound healed successfully in all
patients.
In 13 patients, an angiography was performed at least
once between 11 and 42 months postoperatively that
showed patent bypasses without significant abnormalities
in all cases. The artery of the flap was visualized as a lateral
distal branch of the arterial graft in each patient (Fig 2). In
six patients, a rich arterial network into the muscle flap and
in nearby tissues was observed and suggested a neovascu-
larization from the muscle flap.
A review of 17 patients was done in June 2007 (1 death,
2 amputations). The DUS surveillance showed patency of
the Y-SCAFT (arterial autograft and pedicle of the flap)
without significant stenosis in all 17 patients. The median
blood pressure at ankle level was 110 mm Hg (range,
Fig 3. Data of ankle-brachial index (ABI) before and after sur-
gery. Solid line: median; hinges: 25th and 75th percentiles (height
of box: inter-quartile range); whiskers: extremes values observed.
Statistically significant differences were found between preopera-
tive and postoperative findings (P  .001; Wilcoxon test).90-120 mmHg). At 2 years, the limb salvage rate was 85%,
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Toward the end of the follow-up, the healing of the
lower limbs and effective weight bearing were maintained.
The patients recovered normal walking capacity and auton-
omy. The physical aspect of the muscle flap varied during
follow-up. During the first 4 months, it was an erythemal
swollen flap. The edema disappeared at approximately 2
months, and the skin recovered its usual color. Between
months 3 and 8 after the intervention, we could observe the
regression of the excessive muscle volume. The esthetic
status of the flap was acceptable, as well as the donor site
cicatrization. The functional result in the weight-bearing
surfaces was satisfactory (Fig 5).
DISCUSSION
Patients with critical limb ischemia and a large tissue
defect may require major lower limb amputation owing to
Fig 4. Kaplan-Meier curves of (A) survival, (B) limb s
artery Y-shaped flow-through muscle flap in 20 patients.tissue loss rather than arterial occlusion. In selected pa-tients, these problems can be treated using free flap transfer
combined with distal bypass surgery.13-15
The use of the Y-SCAFT technique for revasculariza-
tion and cover of tissue loss with the same anatomic unit is
attractive. The concept involved is supported by our pre-
ceding anatomic research.9 In the present study, we have
evidenced the clinical feasibility of this technique in all 20
patients: this method achieved 85% limb salvage in 17
patients destined for leg amputation. The patency of the
arterial graft of the Y-SCAFT flap was 94%, which compares
easily with the results obtained with distal vein graft.16
The results achieved by the combination of a vascular
bypass and a free-flap transfer are based on relatively short
(100 patients), nonrandomized, and uncontrolled se-
ries.3,13-15 For some authors,3,14 diabetes or dialysis are
contraindications to this technique.
Certain cases of important ischemic tissue loss can be
treated by means of revascularization of the limb, débride-
e, and (C) graft patency after treatment by subscapularalvagment, and vacuum-assisted wound closure. The technique
ll-thi
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wounds with exposure of the tendons covered with peri-
tendon tissue, bone covered with periosteum, and in joints
without exposure of the joint surface.17 This is due to the
presence of vascularized tissue capable of cicatrization.
Conversely, in patients with exposure of the bone without
periosteum, exposure of the tendon without peritendon,
and exposure of the joint surface, the cover with a free flap
is recommended.15 In the experience of Tukiainen et al13
among 2157 revascularizations for critical limb ischemia
manifested as tissue lesions, only 81 (3.7%) were treated
with combined microvascular free flap. We have come to
the conclusion that the most important element of decision
making is the patient’s state of mind and wish to preserve
autonomy.
In our experience, the choice between the Y-SCAFT
technique and combined surgery (vascular reconstruction
and microvascular free-flap transfer) is determined by the
distance between the tissue loss and the site of the potential
distal anastomosis. This distance is limited to 14 cm for
the Y-SCAFT technique. As a consequence, reconstruction
by means of traditional bypass and free flap is applied in the
other cases.
We consider the Y-SCAFT technique as the preferred
graft for the following reasons:
● it is an arterial autograft particularly suitable for small
arterial diameters,
● it allows for revascularization and cover of tissue loss
Fig 5. Photographs show patient (A) postoperatively a
flow-through (Y-SCAFT) muscle flap treatment and a fuwith one anatomic unit,● the graft enables coverage of the ischemic tissue defect
at the distal part of the limb, and
● the Y-shaped configuration limits the number of anas-
tomoses and, presumably, yields hemodynamic advan-
tage in the graft.
The present technique is an evolution of the concept of
a bypass combined with a free flap presenting some com-
mon advantages with this technique. A free flap combined
with a bypass may be performed during one intervention or
as a two-step technique; the Y-SCAFT technique must be
performed during a single intervention.
Like several authors,13,15 we prefer simultaneous revas-
cularization and flap placement rather than a two-step
technique. The advantages of the simultaneous approach
are to avoid reintervention on the same area, to avoid two
general anesthesias, and to shorten hospitalization. The
most interesting advantage of the free flap as well as Y-
SCAFT technique is the hemodynamic combination: the
connection of the flap to the bypass decreases distal resis-
tance and increases the flow in the bypass. This effect was
confirmed by a hemodynamic prospective study of Loren-
zetti et al4 that showed flap transfer increased the flow of an
infrapopliteal graft by about 50%.
The superiority of the arterial autograft compared with
the venous graft has been confirmed by experimental stud-
ies18-20 and by the large experience of coronary bypass
grafting.21,22 Advantages of arterial grafts include the ab-
sence of valves, favorable geometry, and handling charac-
) results at 16 months after subscapular artery Y-shaped
ckness skin graft to cover the weight-bearing surfaces.nd (Bteristics that are superior to those of vein grafts. When the
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intact, free arterial grafts have patency rates that are similar
to those of in situ arterial reconstructions (transposition)
and are superior to those of vein grafts.19 In appropriately
prepared arterial grafts, endothelial cell detachment is rarely
seen except at the site of anastomosis, whereas in vein
grafts, most endothelial cells detach within a few hours and
are replaced only after days or weeks of ingrowth. Further-
more, prostacyclin is produced more abundantly in arterial
grafts than in vein grafts for at least 21 days, and possibly
longer, resulting in antithrombogenic activity.23 The ad-
vantage of the arterial autograft for distal revascularization
of the lower limbs has been signalled recently.7 Published
data on inframalleolar bypass using autogenous arterial
grafts have yielded the patency 82% at 3 years.6 The disad-
vantage of arterial grafts is the relative limit of length
compared with venous grafts.
The Y-SCAFT technique presently studied preserves
the hemodynamic advantages of the association of venous
bypass and free flap, is simpler to perform, and has the
advantage of using only autologous arterial material when-
ever possible.
One of the first applications of flow-through free flap
for salvage of femoropedal bypass graft using a RAFT flap
was publicized by Gooden et al5 in 1997. Recently, a series
of 10 patients treated for arterial lesions with tissue loss by
RAFT flap has been reported.24 This technique enables
treatment of tissue loss exclusively on the revascularization
axis of the bypass because the cutaneous flap is sustained by
the short septal branches of the radial artery, which limits
considerably the use of this kind of flap. Musculocutaneous
flaps are not adequate for tissue loss at the foot or ankle
level: they are thick and slippery, which is inconvenient for
walking.3,13
The technique of the serratus anterior muscle flap and
the subscapular area with arterial T or Y grafts have already
been published.25-27 The graft remains quite short, and the
flap supply being situated in the proximal part of the graft
does not yield hemodynamic advantage.
The proximity of tissue loss and distal anastomosis
represents a danger of infection.28 In four patients of this
series, we used the same flap to cover the tissue loss and the
distal part of the graft, including the anastomosis, and
healing was achieved without complication. We can pre-
sume that the presence of autologous arterial material and
the absence of anastomosis between bypass and flap con-
tributed to this success.
CONCLUSIONS
We have evidenced the feasibility of an innovative Y-
SCAFT technique that allows for revascularization and
covering of tissue loss with the same anatomic unit. This
technique preserves the hemodynamic advantage of the
association of venous bypass and the free flap by decreasing
the vascular resistance. Fewer anastomoses make it less
complicated to perform, and it has the advantage of using
autologous arterial material of adequate diameter, particu-
larly for distal anastomoses. This clinical study evidencesthe efficacy of Y-SCAFT muscle flap for limb salvage in the
worst situation of critical limb ischemia.
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